Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sepax Technologies is a private Delaware-based life science tools company focused on chromatography products and services for biological separation, bioanalysis, and downstream bioprocess purification. The company develops and manufactures HPLC columns, bulk resins/media, and related equipment used for characterization and purification of biologics including monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, proteins, AAV, VLP, DNA, RNA, and mRNA. Sepax also provides customized method development, resin/media, and scale-up purification services for biopharma customers from research through commercial manufacturing support. Its capabilities are built on proprietary expertise in base bead synthesis, surface modification, linker and organic synthesis chemistry, protein chemistry, and column packing. The business appears to operate as a commercial supplier rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sepax Technologies.